Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1
Status:
Completed
Trial end date:
2013-08-01
Target enrollment:
Participant gender:
Summary
This study is a prospective randomized, open label, controlled, double arm, post-marketing
study to compare the treatment efficacy of first-line antimuscarinics and α-blockers
monotherapy for men with moderate to severe lower urinary tract symptoms (LUTS)
(International Prostate Symptom Score (IPSS-T) ≥8) and IPSS voiding-to-storage subscore ratio
(IPSS-V/S) ≤1.